Company description

For over 40 years, Apotex has been a trusted name in the Canadian pharmaceutical community, providing patients with increased access to quality, affordable medicines.  A global company, we operate distinct lines of business including Global Generics (with 300+ prescription and OTC drugs in over 4000 doses and formats), Apotex Pharmachem (with 200+ API’s developed for major markets), Apobiologix for biosimilars and complex molecule development, and ApoPharma for innovative medicines.   Apotex Inc. offers a wide out-licensing portfolio of over 100 finished drug products and 200 active pharmaceutical ingredients (API), backed by a robust development pipeline focused on the top global generic priorities.    Apotex Inc. is also interested in licensing pharmaceuticals from drug development/delivery companies who want to grow their business in the US, Canada, Caribbean, EMEA, APAC, and LATAM markets by utilizing our “Best in Class” commercial teams to sell, market and distribute their products.      Since our founding, we have been dedicated to maintaining sustainable, state-of-the-art processes – processes that ensure our products meet the highest quality and safety standards in all markets. Through our unwavering commitment to excellence and innovation, we help communities across the world live longer, healthier lives.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: APIs |Finished Dosage Forms |Biopharmaceuticals More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 22B22 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 80H100 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Apotex